(Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | (Q3)Jul 31, 2023 | (Q2)Apr 30, 2023 | (Q1)Jan 31, 2023 | (FY)Oct 31, 2022 | (Q4)Oct 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -81.03%2.03B | 116.30%3.99B | -7.64%18.31B | 93.48%9.59B | -80.07%3.56B | 643.13%10.68B | -294.57%-24.47B | 184.31%19.82B | -88.75%4.96B | 71.21%17.86B |
Net income from continuing operations | 19.17%1.87B | 81.34%1.87B | 871.43%1.29B | -67.67%4.38B | -63.19%1.65B | 14.65%1.57B | -78.36%1.03B | -95.47%133M | 74.58%13.54B | 107.64%4.48B |
Operating gains losses | -36.11%-49M | -131.43%-81M | 82.67%-13M | 28.17%-181M | -225.00%-35M | 57.65%-36M | 59.30%-35M | 31.19%-75M | 57.36%-252M | 115.56%28M |
Depreciation and amortization | -3.64%530M | -7.09%524M | 38.54%532M | 41.82%2.1B | 58.58%601M | 49.86%550M | 56.23%564M | 2.95%384M | -5.43%1.48B | -4.29%379M |
Provision for loans, leases and other losses | 84.15%906M | -31.09%705M | 188.94%627M | 595.85%2.18B | 97.35%446M | 261.76%492M | 1,946.00%1.02B | 319.19%217M | 1,465.00%313M | 279.37%226M |
Deferred tax | 126.69%146M | -1,153.33%-376M | 221.74%112M | -254.11%-732M | -14.55%-63M | -592.41%-547M | -107.04%-30M | -150.27%-92M | 158.15%475M | -96.43%-55M |
Change in working capital | -115.85%-1.37B | 105.00%1.35B | -18.16%15.76B | 117.46%1.85B | -92.49%961M | 335.80%8.65B | -482.21%-27.02B | 171.87%19.26B | -130.86%-10.6B | 56.34%12.8B |
-Change in loans | -81.66%-12.76B | 168.61%8.96B | 209.83%9.05B | 57.33%-31.52B | 80.06%-3.2B | 62.16%-7.02B | 25.27%-13.06B | 62.20%-8.24B | -508.53%-73.87B | -3,510.81%-16.03B |
-Change in other working capital | -27.36%11.39B | 45.54%-7.61B | -75.61%6.71B | -47.26%33.37B | -85.63%4.16B | 6.09%15.68B | -156.97%-13.97B | 654.32%27.5B | 34.16%63.27B | 213.07%28.94B |
Cash from discontinued operating activities | ||||||||||
Operating cash flow | -81.03%2.03B | 116.30%3.99B | -7.64%18.31B | 93.48%9.59B | -80.07%3.56B | 643.13%10.68B | -294.57%-24.47B | 184.31%19.82B | -88.75%4.96B | 71.21%17.86B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -232.63%-5.15B | 113.52%1.8B | -107.46%-12.62B | 28.21%-21.16B | -68.70%-5.65B | 444.20%3.89B | -813.18%-13.31B | 77.35%-6.08B | -9,756.52%-29.47B | -112.63%-3.35B |
Proceeds payment in interest bearing deposits in bank | 61.76%791M | 68.47%-35M | -137.18%-203M | -49.34%1.68B | -62.85%756M | 30.05%489M | -111.36%-111M | 858.33%546M | 2,202.78%3.32B | 397.56%2.04B |
Net PPE purchase and sale | -3.16%-196M | 26.73%-148M | -33.33%-232M | -13.90%-885M | -5.98%-319M | -8.57%-190M | -21.69%-202M | -28.89%-174M | -60.54%-777M | -91.72%-301M |
Net intangibles purchas and sale | -21.91%-217M | 10.95%-179M | 17.10%-160M | -18.03%-792M | -17.65%-220M | 5.32%-178M | -24.07%-201M | -44.03%-193M | -34.47%-671M | -32.62%-187M |
Net business purchase and sale | --0 | --0 | --0 | -1,331.81%-15.1B | --5M | ---155M | -186,475.00%-14.91B | -103.45%-42M | 1,846.03%1.23B | --0 |
Net investment purchase and sale | -241.12%-5.53B | 2.13%2.16B | -93.33%-12.02B | 81.40%-6.06B | -19.95%-5.88B | 443.26%3.92B | 75.02%2.12B | 77.58%-6.22B | -6,927.04%-32.57B | -190.34%-4.9B |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -232.63%-5.15B | 113.52%1.8B | -107.46%-12.62B | 28.21%-21.16B | -68.70%-5.65B | 444.20%3.89B | -813.18%-13.31B | 77.35%-6.08B | -9,756.52%-29.47B | -112.63%-3.35B |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -743.46%-2.19B | -217.92%-1.83B | -378.76%-7.48B | -98.32%268M | -399.60%-3.71B | -110.03%-260M | -73.47%1.55B | -57.43%2.68B | 411.99%15.98B | -13.31%1.24B |
Net issuance payments of debt | -67.81%909M | 96.46%-93M | -301.16%-2.42B | -139.68%-3.1B | -311.39%-2.69B | 12,736.36%2.82B | -180.15%-2.63B | -118.65%-603M | 722.07%7.81B | -48.59%1.27B |
Net commonstock issuance | 240.00%17M | 90.00%19M | -99.40%20M | 8.30%3.35B | 3,000.00%29M | -54.55%5M | -99.67%10M | 15,657.14%3.31B | 1,847.17%3.1B | 92.31%-1M |
Net preferred stock issuance | --168M | --1.35B | --0 | -13.02%648M | --0 | --0 | --0 | --648M | 171.22%745M | 306.21%598M |
Cash dividends paid | -67.79%-1.25B | -5.52%-669M | -11.03%-745M | -4.16%-2.7B | -3.63%-656M | -23.87%-742M | -2.76%-634M | 10.05%-671M | 12.92%-2.6B | 15.15%-633M |
Net other financing activities | 13.00%-2.04B | -150.72%-2.44B | ---4.34B | -70.15%2.07B | ---388M | -174.25%-2.35B | 16,662.07%4.8B | ---- | --6.93B | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -743.46%-2.19B | -217.92%-1.83B | -378.76%-7.48B | -98.32%268M | -399.60%-3.71B | -110.03%-260M | -73.47%1.55B | -57.43%2.68B | 411.99%15.98B | -13.31%1.24B |
Net cash flow | ||||||||||
Beginning cash position | 16.61%79.87B | -27.76%74.66B | -10.90%77.93B | -6.21%87.47B | 16.78%81.26B | -2.55%68.5B | 106.18%103.34B | -6.21%87.47B | 62.45%93.26B | -16.99%69.59B |
Current changes in cash | -137.20%-5.32B | 110.93%3.96B | -110.89%-1.79B | -32.39%-11.3B | -136.83%-5.8B | 2,949.40%14.3B | -278.55%-36.23B | 137.27%16.43B | -122.09%-8.53B | 53.13%15.75B |
Effect of exchange rate changes | 113.86%213M | -9.34%1.25B | -170.86%-1.49B | -35.52%1.77B | 15.74%2.47B | -676.26%-1.54B | 1,187.40%1.38B | -159.10%-549M | 198.70%2.74B | 352.36%2.14B |
End cash position | -8.00%74.76B | 16.61%79.87B | -27.76%74.66B | -10.90%77.93B | -10.90%77.93B | 16.78%81.26B | -2.55%68.5B | 106.18%103.34B | -6.21%87.47B | -6.21%87.47B |
Free cash from | -84.35%1.61B | 114.72%3.66B | -7.91%17.92B | 125.53%7.91B | -82.61%3.02B | 542.68%10.31B | -303.07%-24.87B | 181.81%19.46B | -91.85%3.51B | 71.43%17.37B |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.